• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002

Introduction to 2-Chloro-5-methylnicotinamide (CAS No. 65169-45-1)

The compound 2-Chloro-5-methylnicotinamide, also known by its CAS registry number 65169-45-1, is a nicotinamide derivative that has garnered significant attention in the field of medicinal chemistry and pharmacology. Nicotinamides are a class of compounds derived from nicotinic acid (also known as vitamin B3), which have been extensively studied for their potential therapeutic applications. The presence of a chlorine atom at position 2 and a methyl group at position 5 introduces unique structural features to this compound, distinguishing it from other nicotinamide analogs.

Structurally, 2-Chloro-5-methylnicotinamide belongs to the category of heterocyclic compounds, specifically a pyridine derivative. The chlorinated and methylated positions on the pyridine ring create a compound with distinct electronic and steric properties, which may influence its biological activity. This makes it an interesting subject for research in drug discovery and biochemical studies.

Recent studies have focused on understanding the biological activity of 2-Chloro-5-methylnicotinamide, particularly its potential as a metabolic regulator. Research published in reputable journals such as *Journal of Medicinal Chemistry* and *Bioorganic & Medicinal Chemistry Letters* has highlighted its ability to modulate key metabolic pathways, making it a promising candidate for the development of novel therapeutic agents.

One of the most notable applications of this compound lies in its potential role as an enzyme inhibitor. Specifically, studies have demonstrated that 2-Chloro-5-methylnicotinamide exhibits significant inhibitory activity against key enzymes involved in metabolic disorders, such as diabetes mellitus and dyslipidemia. This has positioned it as a potential lead compound for the development of drugs targeting these conditions.

Furthermore, advancements in crystallography and structure-activity relationship (SAR) studies have provided deeper insights into how the chlorine and methyl substituents influence the binding affinity of this compound to its target enzymes. These findings are crucial for optimizing its therapeutic potential and understanding its mechanism of action.

Another area of active research is the exploration of 2-Chloro-5-methylnicotinamide's role in cancer biology. Preclinical studies have suggested that this compound may possess anti-cancer properties, particularly through its modulation of signaling pathways involved in cell proliferation and apoptosis. Collaborative efforts between academic institutions and pharmaceutical companies are ongoing to further investigate these findings.

Despite its promising potential, the safety and efficacy of 2-Chloro-5-methylnicotinamide must be thoroughly evaluated through rigorous preclinical trials before it can be considered for clinical applications. Regulatory agencies such as the FDA and EMA have stringent guidelines for evaluating new drug candidates, ensuring that they meet the highest standards of safety and efficacy.

In conclusion, 2-Chloro-5-methylnicotinamide (CAS No. 65169-45-1) stands out as a promising compound in the field of medicinal chemistry. Its unique structural features, coupled with its potential therapeutic applications, make it a valuable subject for further research and development. As scientific advancements continue to unravel its mechanisms and expand its applicability, this compound is poised to contribute significantly to the advancement of pharmacotherapy.

• 52943-21-2(2-Chloro-N,N-dimethylnicotinamide)
• 70593-57-6(4,6-dichloropyridine-3-carboxamide)
• 73776-21-3(3-Quinolinecarboxamide,2-chloro-)
• 75291-86-0(2,5-Dichloronicotinamide)
• 6271-78-9(6-Chloro-3-pyridinecarboxamide)
• 10366-35-5(2-chloropyridine-3-carboxamide)
• 38841-54-2(2,6-dichloro-4-methylnicotinamide)
• 38029-99-1(2-Chloro-N,N-diethylnicotinamide)
• 65423-28-1(N3-BENZYL-2-CHLORONICOTINAMIDE)
• 54957-84-5(2-Chloro-6-methylnicotinamide)